Microsoft has launched EvoDiff, a universal framework for generating "high-fidelity and "diverse" proteins based on protein sequences without requiring structural information about the target protein, thus eliminating the most cumbersome steps. The technology applies to the creation of novel therapeutic drug enzymes.
Microsoft Launches EvoDiff, a Protein Generation Framework With a Model Containing 640 Million Parameters at Its Core
Previous: 武大教授蔡恒进：元宇审是人类进入AI世界的入口
Next: 谷歌拟放弃博通 转向自主研发AI芯片